Comparative analysis of the discovery cohort demonstrated a statistically significant elevation in IL-17A concentrations in NPC subjects (median [IQR]: 5.68 [1.24, 14.7]) relative to PC controls (median [IQR]: 0.67 [0.13, 5.18]; p = 0.001). The gene discussed is IL17A; the disease is nasopharyngeal carcinoma.